Skip to main content
Erschienen in: Abdominal Radiology 5/2013

01.10.2013

Imaging bile duct tumors: staging

verfasst von: Juan-Ramón Ayuso, Mario Pagés, Anna Darnell

Erschienen in: Abdominal Radiology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Cholangiocarcinoma (CC) is the most frequent neoplasm of the biliary system. According to its anatomic origin in the biliary tree it is usually classified as intrahepatic, perihilar, or extrahepatic distal CC. Tumors originated in these areas differ in biological behavior and management. The stratification of the patients aligned to therapeutic options and prognosis is a key point in the management of CC. Thus, specific staging systems have been designed for each anatomical location. They are precise for surgical planning, to establish prognosis after surgery, or to compare the benefits of different therapeutic approaches, but they are less accurate to stratify patients into a therapeutic decision algorithm. Imaging tools, mainly multidetector computed tomography and magnetic resonance imaging (MRI), allow full assessment of the diagnosis and extension of the tumor. They are especially useful in establishing the correct diagnosis and determining resectability, which reaches a high negative predictive value, identifying those patients in whom surgery will not be effective. We will discuss the different staging systems for CC, the radiologic characteristics with classical and recently described signs that allow a confident diagnosis of the disease and the criteria for resectability of biliary tract malignancies.
Literatur
1.
Zurück zum Zitat Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288–291PubMedCrossRef Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288–291PubMedCrossRef
2.
Zurück zum Zitat Razumilava N, Gores GJ (2013) Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol 11:13–21PubMedCrossRef Razumilava N, Gores GJ (2013) Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol 11:13–21PubMedCrossRef
3.
Zurück zum Zitat Deoliveira ML, Schulick RD, Nimura Y, et al. (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53:1363–1371PubMedCrossRef Deoliveira ML, Schulick RD, Nimura Y, et al. (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53:1363–1371PubMedCrossRef
4.
Zurück zum Zitat Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8:512–522PubMedCrossRef Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8:512–522PubMedCrossRef
5.
Zurück zum Zitat Deoliveira ML, Cunningham SC, Cameron JL, et al. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762PubMedCrossRef Deoliveira ML, Cunningham SC, Cameron JL, et al. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762PubMedCrossRef
6.
Zurück zum Zitat Singh MK, Facciuto ME (2012) Current management of cholangiocarcinoma. Mt Sinai J Med 79:232–245PubMedCrossRef Singh MK, Facciuto ME (2012) Current management of cholangiocarcinoma. Mt Sinai J Med 79:232–245PubMedCrossRef
7.
Zurück zum Zitat Jonas S, Thelen A, Benckert C, et al. (2009) Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 249:303–309PubMedCrossRef Jonas S, Thelen A, Benckert C, et al. (2009) Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 249:303–309PubMedCrossRef
8.
Zurück zum Zitat Lang H, Sotiropoulos GC, Sgourakis G, et al. (2009) Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208:218–228PubMedCrossRef Lang H, Sotiropoulos GC, Sgourakis G, et al. (2009) Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208:218–228PubMedCrossRef
9.
Zurück zum Zitat Uenishi T, Kubo S, Yamazaki O, et al. (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422PubMedCrossRef Uenishi T, Kubo S, Yamazaki O, et al. (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422PubMedCrossRef
10.
Zurück zum Zitat Nathan H, Aloia TA, Vauthey JN, et al. (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:14–22PubMedCrossRef Nathan H, Aloia TA, Vauthey JN, et al. (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:14–22PubMedCrossRef
11.
Zurück zum Zitat Edge SB (2009) American Joint Committee on Cancer: AJCC cancer staging manual, 7th edn. New York: Springer Edge SB (2009) American Joint Committee on Cancer: AJCC cancer staging manual, 7th edn. New York: Springer
12.
Zurück zum Zitat Farges O, Fuks D, Le Treut YP, et al. (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 Study Group. Cancer 117:2170–2177PubMedCrossRef Farges O, Fuks D, Le Treut YP, et al. (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 Study Group. Cancer 117:2170–2177PubMedCrossRef
13.
Zurück zum Zitat Sotiropoulos GC, Miyazaki M, Konstadoulakis MM, et al. (2010) Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int 30:996–1002PubMedCrossRef Sotiropoulos GC, Miyazaki M, Konstadoulakis MM, et al. (2010) Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int 30:996–1002PubMedCrossRef
14.
Zurück zum Zitat Marsh RW, Alonzo M, Bajaj S, et al. (2012) Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology. J Surg Oncol 106:332–338CrossRef Marsh RW, Alonzo M, Bajaj S, et al. (2012) Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology. J Surg Oncol 106:332–338CrossRef
15.
Zurück zum Zitat Valls C, Guma A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496PubMedCrossRef Valls C, Guma A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496PubMedCrossRef
16.
Zurück zum Zitat Kim SA, Lee JM, Lee KB, et al. (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern—correlation with clinicopathologic findings. Radiology 260:148–157PubMedCrossRef Kim SA, Lee JM, Lee KB, et al. (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern—correlation with clinicopathologic findings. Radiology 260:148–157PubMedCrossRef
17.
Zurück zum Zitat Rimola J, Forner A, Reig M, et al. (2009) Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 50:791–798PubMedCrossRef Rimola J, Forner A, Reig M, et al. (2009) Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 50:791–798PubMedCrossRef
18.
Zurück zum Zitat Park HJ, Kim YK, Park MJ, Lee WJ (2012) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging. doi:10.1007/s00261-012-9943-x Park HJ, Kim YK, Park MJ, Lee WJ (2012) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging. doi:10.​1007/​s00261-012-9943-x
19.
Zurück zum Zitat Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21:59–65PubMedCrossRef Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21:59–65PubMedCrossRef
20.
Zurück zum Zitat Okabayashi T, Yamamoto J, Kosuge T, et al. (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383PubMedCrossRef Okabayashi T, Yamamoto J, Kosuge T, et al. (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383PubMedCrossRef
21.
Zurück zum Zitat Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751–760PubMedCrossRef Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751–760PubMedCrossRef
22.
Zurück zum Zitat Vilgrain V (2008) Staging cholangiocarcinoma by imaging studies. HPB (Oxford) 10:106–109CrossRef Vilgrain V (2008) Staging cholangiocarcinoma by imaging studies. HPB (Oxford) 10:106–109CrossRef
23.
Zurück zum Zitat Kim JY, Kim MH, Lee TY, et al. (2008) Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol 103:1145–1151PubMedCrossRef Kim JY, Kim MH, Lee TY, et al. (2008) Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol 103:1145–1151PubMedCrossRef
24.
Zurück zum Zitat Lee SW, Kim HJ, Park JH, et al. (2010) Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol 45:560–566PubMedCrossRef Lee SW, Kim HJ, Park JH, et al. (2010) Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol 45:560–566PubMedCrossRef
25.
Zurück zum Zitat Corvera CU, Blumgart LH, Akhurst T, et al. (2008) 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206:57–65PubMedCrossRef Corvera CU, Blumgart LH, Akhurst T, et al. (2008) 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206:57–65PubMedCrossRef
26.
Zurück zum Zitat Marsh RW, Alonzo M, Bajaj S, et al. (2012) Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. J Surg Oncol 106:339–345CrossRef Marsh RW, Alonzo M, Bajaj S, et al. (2012) Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. J Surg Oncol 106:339–345CrossRef
27.
Zurück zum Zitat Dhanasekaran R, Hemming AW, Zendejas I, et al. (2013) Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep 29:1259–1267PubMed Dhanasekaran R, Hemming AW, Zendejas I, et al. (2013) Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep 29:1259–1267PubMed
28.
Zurück zum Zitat Bismuth H, Corlette MB (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170–178PubMed Bismuth H, Corlette MB (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170–178PubMed
29.
Zurück zum Zitat Jarnagin WR, Fong Y, DeMatteo RP, et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–517PubMedCrossRef Jarnagin WR, Fong Y, DeMatteo RP, et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–517PubMedCrossRef
30.
Zurück zum Zitat Matsuo K, Rocha FG, Ito K, et al. (2012) The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215:343–355PubMedCrossRef Matsuo K, Rocha FG, Ito K, et al. (2012) The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215:343–355PubMedCrossRef
31.
Zurück zum Zitat Zervos EE, Osborne D, Goldin SB, et al. (2005) Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg 190:810–815PubMedCrossRef Zervos EE, Osborne D, Goldin SB, et al. (2005) Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg 190:810–815PubMedCrossRef
32.
Zurück zum Zitat Nagino M (2011) Perihilar cholangiocarcinoma: a much needed but imperfect new staging system. Nat Rev Gastroenterol Hepatol 8:252–253PubMed Nagino M (2011) Perihilar cholangiocarcinoma: a much needed but imperfect new staging system. Nat Rev Gastroenterol Hepatol 8:252–253PubMed
33.
Zurück zum Zitat Gore RM, Shelhamer RP (2007) Biliary tract neoplasms: diagnosis and staging. Cancer Imaging 7 Spec No A:S15–S23 Gore RM, Shelhamer RP (2007) Biliary tract neoplasms: diagnosis and staging. Cancer Imaging 7 Spec No A:S15–S23
34.
Zurück zum Zitat Masselli G, Gualdi G (2008) Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 33:444–451PubMedCrossRef Masselli G, Gualdi G (2008) Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 33:444–451PubMedCrossRef
35.
36.
Zurück zum Zitat Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD (2008) Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 48:1106–1117PubMedCrossRef Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD (2008) Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 48:1106–1117PubMedCrossRef
37.
Zurück zum Zitat Cui XY, Chen HW (2010) Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol 16:3196–3201PubMedCrossRef Cui XY, Chen HW (2010) Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol 16:3196–3201PubMedCrossRef
38.
Zurück zum Zitat Cui XY, Chen HW, Cai S, et al. (2012) Diffusion-weighted MR imaging for detection of extrahepatic cholangiocarcinoma. Eur J Radiol 81:2961–2965PubMedCrossRef Cui XY, Chen HW, Cai S, et al. (2012) Diffusion-weighted MR imaging for detection of extrahepatic cholangiocarcinoma. Eur J Radiol 81:2961–2965PubMedCrossRef
39.
Zurück zum Zitat Kim JE, Lee JM, Kim SH, et al. (2010) Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology 257:364–372PubMedCrossRef Kim JE, Lee JM, Kim SH, et al. (2010) Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology 257:364–372PubMedCrossRef
40.
Zurück zum Zitat Takanami K, Yamada T, Tsuda M, et al. (2011) Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging 36:447–456PubMedCrossRef Takanami K, Yamada T, Tsuda M, et al. (2011) Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging 36:447–456PubMedCrossRef
41.
Zurück zum Zitat Choi JY, Kim MJ, Lee JM, et al. (2008) Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol 191:1448–1457PubMedCrossRef Choi JY, Kim MJ, Lee JM, et al. (2008) Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol 191:1448–1457PubMedCrossRef
42.
Zurück zum Zitat Hattori M, Nagino M, Ebata T, et al. (2011) Prospective study of biliary cytology in suspected perihilar cholangiocarcinoma. Br J Surg 98:704–709PubMedCrossRef Hattori M, Nagino M, Ebata T, et al. (2011) Prospective study of biliary cytology in suspected perihilar cholangiocarcinoma. Br J Surg 98:704–709PubMedCrossRef
43.
Zurück zum Zitat Halling KC, Kipp BR (2007) Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 38:1137–1144PubMedCrossRef Halling KC, Kipp BR (2007) Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 38:1137–1144PubMedCrossRef
44.
Zurück zum Zitat Lee HY, Kim SH, Lee JM, et al. (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239:113–121PubMedCrossRef Lee HY, Kim SH, Lee JM, et al. (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239:113–121PubMedCrossRef
45.
Zurück zum Zitat Kim HJ, Kim AY, Hong SS, et al. (2006) Biliary ductal evaluation of hilar cholangiocarcinoma: three-dimensional direct multi-detector row CT cholangiographic findings versus surgical and pathologic results—feasibility study. Radiology 238:300–308PubMedCrossRef Kim HJ, Kim AY, Hong SS, et al. (2006) Biliary ductal evaluation of hilar cholangiocarcinoma: three-dimensional direct multi-detector row CT cholangiographic findings versus surgical and pathologic results—feasibility study. Radiology 238:300–308PubMedCrossRef
46.
Zurück zum Zitat Masselli G, Manfredi R, Vecchioli A, Gualdi G (2008) MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol 18:2213–2221PubMedCrossRef Masselli G, Manfredi R, Vecchioli A, Gualdi G (2008) MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol 18:2213–2221PubMedCrossRef
47.
Zurück zum Zitat Aloia TA, Charnsangavej C, Faria S, et al. (2007) High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193:702–706PubMedCrossRef Aloia TA, Charnsangavej C, Faria S, et al. (2007) High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193:702–706PubMedCrossRef
48.
Zurück zum Zitat Forsmo HM, Horn A, Viste A, Hoem D, Ovrebo K (2008) Survival and an overview of decision-making in patients with cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 7:412–417PubMed Forsmo HM, Horn A, Viste A, Hoem D, Ovrebo K (2008) Survival and an overview of decision-making in patients with cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 7:412–417PubMed
49.
Zurück zum Zitat Sacks A, Peller PJ, Surasi DS, et al. (2011) Value of PET/CT in the management of primary hepatobiliary tumors, part 2. AJR Am J Roentgenol 197:W260–W265PubMedCrossRef Sacks A, Peller PJ, Surasi DS, et al. (2011) Value of PET/CT in the management of primary hepatobiliary tumors, part 2. AJR Am J Roentgenol 197:W260–W265PubMedCrossRef
50.
Zurück zum Zitat Ruys AT, van Beem BE, Engelbrecht MR, et al. (2012) Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol 85:1255–1262PubMedCrossRef Ruys AT, van Beem BE, Engelbrecht MR, et al. (2012) Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol 85:1255–1262PubMedCrossRef
51.
Zurück zum Zitat Hong SM, Pawlik TM, Cho H, et al. (2009) Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery 146:250–257PubMedCrossRef Hong SM, Pawlik TM, Cho H, et al. (2009) Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery 146:250–257PubMedCrossRef
52.
Zurück zum Zitat Murakami Y, Uemura K, Sudo T, et al. (2010) Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg 211:196–204PubMedCrossRef Murakami Y, Uemura K, Sudo T, et al. (2010) Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg 211:196–204PubMedCrossRef
Metadaten
Titel
Imaging bile duct tumors: staging
verfasst von
Juan-Ramón Ayuso
Mario Pagés
Anna Darnell
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 5/2013
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-013-0021-9

Weitere Artikel der Ausgabe 5/2013

Abdominal Radiology 5/2013 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.